TY - JOUR
T1 - Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®
AU - Sousa-Pinto, Bernardo
AU - Eklund, Patrik
AU - Pfaar, Oliver
AU - Klimek, Ludger
AU - Zuberbier, Torsten
AU - Czarlewski, Wienczyslawa
AU - Bédard, Annabelle
AU - Bindslev-Jensen, Carsten
AU - Bedbrook, Anna
AU - Bosnic-Anticevich, Sinthia
AU - Brussino, Luisa
AU - Cardona, Victoria
AU - Cruz, Alvaro A.
AU - de Vries, Govert
AU - Devillier, Philippe
AU - Fokkens, Wytske J.
AU - Fuentes-Pérez, José Miguel
AU - Gemicioğlu, Bilun
AU - Haahtela, Tari
AU - Huerta-Villalobos, Yunen Rocío
AU - Ivancevich, Juan Carlos
AU - Kull, Inger
AU - Kuna, Piotr
AU - Kvedariene, Violeta
AU - Larenas Linnemann, Désirée E.
AU - Laune, Daniel
AU - Makris, Michael
AU - Melén, Erik
AU - Morais-Almeida, Mário
AU - Mösges, Ralph
AU - Mullol, Joaquim
AU - O'Hehir, Robyn E.
AU - Papadopoulos, Nikolaos G.
AU - Pereira, Ana Margarida
AU - Prokopakis, Emmanuel P.
AU - Psarros, Fotis
AU - Regateiro, Frederico S.
AU - Reitsma, Sietze
AU - Samolinski, Boleslaw
AU - Scichilone, Nicola
AU - da Silva, Jane
AU - Stellato, Cristiana
AU - Todo-Bom, Ana
AU - Tomazic, Peter Valentin
AU - Toppila Salmi, Sanna
AU - Valero, Antonio
AU - Valiulis, Arunas
AU - Valovirta, Erkka
AU - van Eerd, Michiel
AU - Ventura, Maria Teresa
AU - Yorgancioglu, Arzu
AU - Basagaña, Xavier
AU - Antó, Josep M.
AU - Bousquet, Jean
AU - Fonseca, João A.
N1 - Copyright the Author(s) 2021. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.
PY - 2021/8
Y1 - 2021/8
N2 - Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods: Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or “VAS Work” indicating clinical change. Results: A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion: In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads.
AB - Background: MASK-air® is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods: Daily monitoring VAS data were assessed in MASK-air® users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test–retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or “VAS Work” (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or “VAS Work” indicating clinical change. Results: A total of 17,780 MASK-air® users, with 317,176 VAS days, were assessed. Concurrent validity was moderate–high (Spearman correlation coefficient range: 0.437–0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test–retest reliability ICCs ranged between 0.604 and 0.878—“VAS Work” and “VAS asthma” presented the highest ICCs. Moderate/large responsiveness effect sizes were observed—the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion: In MASK-air®, daily monitoring VASs have high intra-rater reliability and moderate–high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads.
KW - allergic rhinitis
KW - mobile health
KW - reliability
KW - responsiveness
KW - visual analog scales
UR - https://www.scopus.com/pages/publications/85115860874
U2 - 10.1002/clt2.12062
DO - 10.1002/clt2.12062
M3 - Review article
C2 - 34567526
SN - 2045-7022
VL - 11
SP - 1
EP - 15
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
IS - 7
M1 - e12062
ER -